Status:

COMPLETED

Effect of Combination Dexmedetomidine Added to Fentanyl-based Intravenous Patient-controlled Analgesia on Nausea Vomiting in Highly Susceptible Patients Undergoing Lumbar Spinal Surgery: Prospective Double Blinded Randomized Controlled Trial

Lead Sponsor:

Yonsei University

Conditions:

PONV

Eligibility:

FEMALE

20-65 years

Phase:

NA

Brief Summary

The aim of this study is to test the hypothesis that addition of dexmedetomidine to fentanyl-based intravenous patient controlled analgesia (PCA) reduces requirement of fentanyl bolus and consequent p...

Eligibility Criteria

Inclusion

  • 1\. female, non-smoking patient who are 20-65 of age scheduled for elective lumbar spine surgery

Exclusion

  • Bradycardia on EKG (45bpm)
  • Atrioventricular conduction disorder
  • Uncontrolled hypertension
  • angina history
  • obesity (BMI ≥ 30 kg/m2)
  • Preoperative administration of opioid
  • Preoperative administration of antiemetics
  • Gastrointestinal disorder history
  • Hepatic or renal disease
  • Pregnant 11. Foreigner

Key Trial Info

Start Date :

September 1 2012

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2013

Estimated Enrollment :

108 Patients enrolled

Trial Details

Trial ID

NCT01840254

Start Date

September 1 2012

End Date

September 1 2013

Last Update

February 7 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Yonsei University College of Medicine

Seoul, Seoul, South Korea, 120-752

Effect of Combination Dexmedetomidine Added to Fentanyl-based Intravenous Patient-controlled Analgesia on Nausea Vomiting in Highly Susceptible Patients Undergoing Lumbar Spinal Surgery: Prospective Double Blinded Randomized Controlled Trial | DecenTrialz